Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
The total weight loss at 48 weeks is higher with retatrutide
Breast, liver, colorectal and non-small cell lung cancer risks declined significantly
Changes often develop gradually as antioxidant support strengthens cellular balance
At moderate doses (4-8mg), the triple-receptor synergy kicks in fully
Retatrutide (LY3437943, also referred to informally as "reta peptide") is a synthetic 39-amino-acid peptide developed by Eli Lilly that acts simultaneously on three distinct metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor
US$ 20.76
US$ 27.97
US$ 21.91
US$ 25.16
US$ 22.29
US$ 28.81
US$ 21.06
